Farms.com Home   News

NASS Small Grains Summary

The U.S. Department of Agriculture National Agricultural Statistics Service (NASS) released its Small Grains 2024 Summary on September 30, focusing on the production of wheat and barley in Washington State, as well as providing national figures. It highlights year-over-year changes and compares the data to the 5-year production average. The report breaks down wheat production into winter and spring categories, further detailing by-class figures for the 5 wheat varieties grown in Washington State. Barley production trends are also discussed, showing regional increases despite national decreases.

On a national scale, total 2024 US wheat production is estimated at 1,971,301,000 bushels (approximately 53,299,037 MT), showing a 9% increase in production compared to the year prior and aligning with the 10% increase over the 5-year average. Washington ranked fourth in overall wheat production.

Some additional highlights for Washington state include:

Winter Wheat

Production is estimated at 122,500,000 bushels (3,333,968 MT), reflecting a 30% increase from last year and exceeding the 5-year average of 108,676,000 bushels. 90% Soft White, 10% Hard Red Winter. Statewide average yields were reported as 70 bu/ac, up from 54 bu/ac last year.

Spring Wheat

The current estimate stands at 21,070,000 bushels (573,443 MT), which is a 13% increase from last year’s figures but slightly below the 5-year average of 22,151,000 bushels. 83% Soft White, 23% Hard Red Spring, 1% Hard White. Statewide average yields were reported as 43 bu/ac, up from 38 bu/ac last year.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.